GroPep announces Japanese approval of biopharmaceutical that uses its cell culture products

Adelaide biotechnology company, GroPep, announced today that a biopharmaceutical product with a key manufacturing ingredient supplied by GroPep has received regulatory approval in Japan.

The product is the sixth biopharmaceutical made with GroPep's Cell Culture Products to have achieved regulatory approval.

Listed biopharmaceutical GroPep Limited (ASX: GRO) has today announced that a sixth biopharmaceutical product that uses the Company's Cell Culture Products in its manufacturing process, has obtained regulatory approval in Japan.

Confidentiality agreements prevent GroPep from naming the specific product or company.

While this specific approval is not likely to generate significant revenue growth for GroPep, the product is also currently undergoing clinical trials for a number of other indications, some of which have multi-billion dollar global markets. Further submissions to regulatory agencies for approval are planned for 2006 and 2007.

CEO Mr Bob Finder said that the Japanese approval reinforces the growing international recognition of the superiority of GroPep's Cell Culture Products in the manufacturing of certain biopharmaceutical products.

GroPep, based at Thebarton, South Australia, listed on the Australian Stock Exchange in August 2000. The company specialises in the development, manufacture and commercialisation of biopharmaceuticals and also biologically active proteins for cell culture and biomedical research.


Contact: Tony Mitchell
Research Australia

Page: 1

Related biology news :

1. GroPep infertility data presented at US meeting
2. GroPep announces US FDA approval of biopharmaceutical that uses its cell culture product
3. Almac Diagnostics announces pioneering genetic research on ductal carcinoma in situ
4. ESA announces 2007 award recipients
5. President Bush announces 2005 and 2006 Laureates of National Medals of Science and Technology
6. Conservation Leadership Program announces 2007 awardees
7. ACMG Foundation announces 2007-2008 Luminex/ACMGF award recipient
8. Revolutionary global environment fund announces $50M expansion
9. Biovest announces interim blinded data of fast-tracked pivotal Phase 3 clinical trial of BiovaxID
10. Cell Press announces new partnership with the American Society of Human Genetics
11. ChemGenex announces publication confirming activity of Ceflatonin in T315I-Positive CML

Post Your Comments:

(Date:8/19/2019)... STATION, N.J. (PRWEB) , ... August 19, 2019 ... ... clinicians have characterized tissues through the use of ultra-thin two dimensional slices which ... paradigm can be highly limited for complex tissues and complicated features such as ...
(Date:8/15/2019)... ... August 15, 2019 , ... Make IVD tests faster, ... tasks. That was the message at the world's largest gathering of laboratory professionals ... Association for Clinical Chemistry (AACC) Annual Scientific Meeting was held in Anaheim, CA, ...
(Date:8/14/2019)... ... August 14, 2019 , ... Join Jonathan Riek, PhD, VP, Musculoskeletal & Metabolic ... 10, 2019 at 1pm EDT to learn about two common imaging methods in NAFLD/NASH ... is the most common diffuse liver disease, with a worldwide prevalence of 20-46 percent. ...
Breaking Biology News(10 mins):
(Date:7/17/2019)... ... July 16, 2019 , ... ... a recent report from Kalorama Information. Abbott, Roche and Siemens Healthineers and Response ... Information’s latest report, Worldwide Market for Point-of-Care (POC) Diagnostics . , Quidel ...
(Date:7/2/2019)... ... 02, 2019 , ... Leading Regenerative Veterinary Medicine company, VetStem Biopharma , ... The film focuses on regenerative veterinary medicine as a means of improving the ... included in the Brentwood and Pacific Palisades International Film Festival in Los Angeles, ...
(Date:6/12/2019)... ... June 12, 2019 , ... ... leak testing instruments for the Pharmaceutical, Biotechnology, Medical Device and Food Packaging Industries, ... been signed. The agreement will grant exclusive rights for Zillion to represent LDA ...
(Date:6/11/2019)... ROANOKE, Va. (PRWEB) , ... June 11, 2019 ... ... for microlearning engagement, and Carilion Clinic, a national leader in opioid treatment, announced ... in virtual care. , Mytonomy recently deployed its virtual care platform ...
Breaking Biology Technology:
Cached News: